{"id":"W2585824977","doi":"10.1371/journal.pbio.2000487","title":"Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"PLoS Biology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Sorafenib; Medicine; Clinical trial; Drug development; Clinical endpoint; Adverse effect; Drug; Cancer; Oncology; Internal medicine; Intensive care medicine; Pharmacology; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003403937,0.0002448061,0.001102843,0.00003444845,0.000103844,0.00001386332,0.0006609008,0.0001630552,0.000003488106],"category_scores_gemma":[0.0006156454,0.0001183896,0.0001661469,0.00007464258,0.0001676154,7.89268e-7,0.0003509975,0.0001426209,0.000001772866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003322376,"about_ca_system_score_gemma":0.000526484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003295785,"about_ca_topic_score_gemma":0.0003991739,"domain_scores_codex":[0.9984282,0.0002877736,0.000699188,0.0003049287,0.00008498318,0.0001949314],"domain_scores_gemma":[0.9984033,0.0001050287,0.0007133647,0.0006873212,0.00006649979,0.00002454613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000007247713,0.0001746382,0.00008054013,0.9085622,0.0005479743,0.00000252348,0.001206807,0.000001433706,0.0003820361,0.0001018441,0.001405129,0.08752765],"study_design_scores_gemma":[0.0001157314,0.00006085111,0.00001801024,0.1602558,0.0007907859,0.00001460427,0.00007794762,0.000001548406,0.0002135277,0.00001241721,0.8381445,0.0002943063],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001779218,0.9960586,0.000001694709,0.000107467,0.0001363076,0.001744073,0.0001080768,0.000001708167,0.00006287049],"genre_scores_gemma":[0.001993717,0.99687,0.00003938389,0.0002726143,0.00004351875,0.0006686097,0.00006442568,0.00001550338,0.00003220618],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8367394,"threshold_uncertainty_score":0.4827786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04615992926865647,"score_gpt":0.3210024279958603,"score_spread":0.2748424987272038,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}